Bruce D. Minsky

The University of Texas MD Anderson Cancer Center

Papers

2

Total Citations

20

H-Index

2

About

Bruce D. Minsky is a leading authority in gastrointestinal radiation oncology, with a career-long focus on optimizing multidisciplinary treatment for rectal cancer. His major contributions center on refining the integration of radiation therapy with surgery and chemotherapy, particularly through the use of neoadjuvant chemoradiotherapy (nCRT) to improve local control and sphincter preservation. A hallmark of his recent work is the pioneering application of robotic lateral pelvic lymph node dissection (LPLND) following nCRT, a technically demanding procedure that addresses persistent nodal disease in the West—a region where such outcomes were previously underreported. His 2020 study on this topic, with 18 citations, provides critical short-term perioperative and oncological data, establishing a new paradigm for managing lateral pelvic nodes. Minsky has also shaped the field by editing special issues on new paradigms in rectal cancer multidisciplinary care, emphasizing collaborative decision-making. With a career spanning decades, his research has been instrumental in advancing personalized, less morbid treatment strategies, making him a key figure in gastrointestinal oncology whose work directly influences modern rectal cancer management.

Research Focus

Key Achievements

2
H-Index
2
Papers
20
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective
18 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago